Javascript must be enabled to continue!
Clinical laboratory–based indicators of psychosocial vulnerability among hospitalised oncology patients
View through CrossRef
Psychosocial vulnerability plays an important role in shaping clinical trajectories and patient experience in oncology, yet its early identification during hospitalisation remains challenging. This retrospective observational study examined whether routinely collected laboratory data could be organised into a composite indicator of psychosocial vulnerability among hospitalised patients with tumour related conditions. Admission laboratory parameters across hepatic, renal, urinary, and haematologic domains were integrated to derive a laboratory based psychosocial vulnerability score, which was categorised into graded vulnerability levels. Associations between vulnerability, diagnostic severity, and length of hospital stay were explored using descriptive analyses, cross tabulation, and ordinal trend testing. Among 107 patients with valid data, laboratory abnormalities across multiple physiological systems were common. While more than half of the cohort was classified as having low or mild vulnerability, a substantial proportion demonstrated moderate to very high vulnerability. Increasing vulnerability was associated with a progressive shift toward more advanced diagnostic categories and longer hospitalisation. Patients with higher vulnerability levels were disproportionately represented among prolonged hospital stays, and a significant ordinal trend was observed between vulnerability category and length of stay. These findings suggest that laboratory based psychosocial vulnerability reflects cumulative physiological stress that is clinically meaningful during inpatient oncology care. Integrating routine laboratory data into vulnerability assessment may support earlier recognition of patients at risk for complex hospital courses and inform more anticipatory, person-centred supportive care strategies.
Title: Clinical laboratory–based indicators of psychosocial vulnerability among hospitalised oncology patients
Description:
Psychosocial vulnerability plays an important role in shaping clinical trajectories and patient experience in oncology, yet its early identification during hospitalisation remains challenging.
This retrospective observational study examined whether routinely collected laboratory data could be organised into a composite indicator of psychosocial vulnerability among hospitalised patients with tumour related conditions.
Admission laboratory parameters across hepatic, renal, urinary, and haematologic domains were integrated to derive a laboratory based psychosocial vulnerability score, which was categorised into graded vulnerability levels.
Associations between vulnerability, diagnostic severity, and length of hospital stay were explored using descriptive analyses, cross tabulation, and ordinal trend testing.
Among 107 patients with valid data, laboratory abnormalities across multiple physiological systems were common.
While more than half of the cohort was classified as having low or mild vulnerability, a substantial proportion demonstrated moderate to very high vulnerability.
Increasing vulnerability was associated with a progressive shift toward more advanced diagnostic categories and longer hospitalisation.
Patients with higher vulnerability levels were disproportionately represented among prolonged hospital stays, and a significant ordinal trend was observed between vulnerability category and length of stay.
These findings suggest that laboratory based psychosocial vulnerability reflects cumulative physiological stress that is clinically meaningful during inpatient oncology care.
Integrating routine laboratory data into vulnerability assessment may support earlier recognition of patients at risk for complex hospital courses and inform more anticipatory, person-centred supportive care strategies.
Related Results
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Abstract
Introduction
Immunoglobulin G4-related disease (IgG4-RD) is a recently identified immune-mediated condition that is debilitating and often overlooked. While IgG4-RD has be...
From Birth to Belonging: Psychosocial Development in Early Childhood
From Birth to Belonging: Psychosocial Development in Early Childhood
The first years of life represent a crucial period in child development. While learning to walk and talk are well-known milestones, children also develop essential social and emoti...
Psychosocial features of stuttering for school‐age children: A systematic review
Psychosocial features of stuttering for school‐age children: A systematic review
AbstractBackgroundContemporary clinical and empirical perspectives indicate that management of the psychosocial features of stuttering is fundamental for effective treatment. Inter...
Next steps in capturing vulnerability dynamics: Introducing a connectivity-based model on systemic vulnerability to multi-hazards
Next steps in capturing vulnerability dynamics: Introducing a connectivity-based model on systemic vulnerability to multi-hazards
Vulnerability has been acknowledged as a dynamic concept since the Pressure and Release model of Blaikie et al. (1994), as well as by other well-known models that integrate this ri...
Accuracy of medical oncology prognosis for patients with metastatic cancer evaluated for enrollment onto an ongoing randomized clinical trial.
Accuracy of medical oncology prognosis for patients with metastatic cancer evaluated for enrollment onto an ongoing randomized clinical trial.
12063 Background: For patients with metastatic cancer, a key aspect of interdisciplinary care has involved the overall prognosis provided by Medical Oncology, which often dictates...
Indicators of infertility and fertility care: a systematic scoping review
Indicators of infertility and fertility care: a systematic scoping review
Abstract
STUDY QUESTION
What is the scope of literature regarding infertility and fertility care indicators in terms of types an...
The IPOS-ECHO African Capacity-Building Program: An Impactful Training Initiative to Disseminate Psycho-Oncology in Africa
The IPOS-ECHO African Capacity-Building Program: An Impactful Training Initiative to Disseminate Psycho-Oncology in Africa
Abstract
Background:
To address the existing disparity in access to psychosocial oncology services in low and middle-inco...

